Treatment for Constipation Due to Ileus
For constipation due to ileus, the treatment approach should focus on prokinetic agents like metoclopramide (10-20 mg PO QID) combined with osmotic laxatives such as polyethylene glycol, while addressing the underlying cause of the ileus. 1
Initial Assessment and Management
- Rule out mechanical obstruction through physical examination and abdominal imaging before initiating treatment 1
- Discontinue any non-essential constipating medications, particularly opioids, antipsychotics, and anticholinergics that may be contributing to the ileus 1, 2
- Assess and treat other potential causes such as electrolyte abnormalities (hypercalcemia, hypokalemia), hypothyroidism, or diabetes mellitus 1
Pharmacological Interventions
First-line Treatments:
- Consider a prokinetic agent such as metoclopramide (10-20 mg PO QID) to stimulate gastrointestinal motility 1
- Initiate osmotic laxatives, with polyethylene glycol (PEG) being the preferred agent (1 capful/8 oz water BID) 1, 3
- For mild cases, fiber supplementation may be considered if adequate fluid intake and physical activity are possible 1
For Opioid-Induced Ileus:
- Methylnaltrexone 0.15 mg/kg subcutaneously every other day (not more than once daily) is recommended for opioid-induced constipation not responding to standard laxative therapy 1, 4
- Methylnaltrexone should NOT be used in patients with postoperative ileus or mechanical bowel obstruction 1
- Other peripherally acting μ-opioid receptor antagonists (PAMORAs) may be beneficial for severe cases 4, 5
For Persistent Constipation:
- Add stimulant laxatives such as bisacodyl (10-15 mg daily to TID) with a goal of one non-forced bowel movement every 1-2 days 1
- For impaction, administer glycerine suppositories or perform manual disimpaction following pre-medication with analgesic and anxiolytic 1
- Consider additional laxatives if needed: bisacodyl suppository (one rectally daily-BID), lactulose (30-60 mL BID-QID), sorbitol (30 mL every 2 hours × 3, then PRN), magnesium hydroxide (30-60 mL daily-BID), or magnesium citrate (8 oz daily) 1
Non-Pharmacological Interventions
- Increase fluid intake and encourage physical activity when appropriate 1
- Provide intravenous hydration if oral intake is inadequate 1, 5
- Consider tap water enemas until clear for severe cases 1
Special Considerations
- In patients with clozapine-induced ileus, dose reduction of the antipsychotic medication may be necessary 2, 6
- For critically ill patients, prevention with bowel management protocols using osmotic laxatives appears to be safe 5, 7
- In patients with cystic fibrosis and distal intestinal obstruction syndrome (DIOS), aggressive treatment with oral laxatives (polyethylene glycol) or intestinal lavage with balanced osmotic electrolyte solution is required 3
Monitoring and Follow-up
- Reassess for cause and severity of constipation if symptoms persist 1
- Monitor for adequate bowel movements with a goal of one non-forced bowel movement every 1-2 days 1
- Recheck for impaction or obstruction if symptoms worsen 1